Intermediates
| No. | Product name | CAS | Structural diagram | API | Status |
|---|---|---|---|---|---|
| 1 | 4-isothiocyanato-2-trifluoroMethylbenzonitrile | 143782-23-4 |  |
Enzalutamide | Commercial |
| 2 | 2-Fluoro-5-3-oxoisobenzofuran-13H-ylidenemethylbenzonitrile | 763114-25-6 |  |
Olaparib | Commercial |
| 3 | 2-fluoro-5-4-oxo-3,4-dihydrophthalazin-1-ylMethylbenzoic acid | 763114-26-7 |  |
Olaparib | Commercial |
| 4 | Dehydronandrolone Acetate | 2590-41-2 |  |
Fulvestrant | Commercial |
| 5 | 7a,17b-7-9-Bromononylestra-1,3,510-triene-3,17-diol | 875573-67-4 |  |
Fulvestrant | Commercial |
| 6 | Estra-1,3,510-triene-3,17-diol,7-9-4,4,5,5,5-pentafluoropentylthiononyl-,17-acetate,7a,17b- | 875573-69-6 |  |
Fulvestrant | Commercial |
| 7 | 7a,17b-7-9-4,4,5,5,5-Pentafluoropentylthiononyl-estra-1,3,510-triene-3,17-diol | 153004-31-0 |  |
Fulvestrant | Commercial |
| 8 | 1-4-BOC-piperidyl-4-iodopyrazole | 877399-73-0 |  |
Crizotinib | Commercial |
| 9 | tert-Butyl 4-4-4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl-1H-pyrazol-1-ylpiperidine-1-carboxylate | 877399-74-1 |  |
Crizotinib | Commercial |
| 10 | R-5-bromo-3-1-2,6-dichloro-3-fluorophenylethoxypyridin-2-amine | 877399-00-3 |  |
Crizotinib | Commercial |
| 11 | 7-Benzyloxy-4-chloro-6-methoxy-quinoline | 286371-49-1 |  |
Anlotinib | Commercial |
| 12 | 6-Methoxy-4-chloro-quinolin-7-0l | 205448-31-3 |  |
Anlotinib | Commercial |
| 13 | Phenol, 2-fluoro-3-2-methyl-1,3-dioxolan-2-ylmethyl-4-nitro- | 2408629-32-1 |  |
Anlotinib | Commercial |
| 14 | benzyl 1-hydroxymethylcyclopropylcarbamate | 103500-22-7 |  |
Anlotinib | Commercial |
| 15 | 5-isothiocyanato-3-trifluoromethylpicolinonitrile | 951753-87-0 |  |
Apalutamide | Commercial |
| 16 | S-tert-Butyl 3-4-aminophenylpiperidine-1-carboxylate | 1171197-20-8 |  |
Niraparib | Commercial |
| 17 | 3-Formyl-2-nitrobenzoic acid methyl ester | 138229-59-1 |  |
Niraparib | Commercial |
| 18 | 2-1-Chloroethoxycarbonylmethylaminopyridin-3-ylmethyl 2-tert-butoxycarbonylmethylaminoacetate | 338990-31-1 |  |
Isavuconazole | Commercial |
| 19 | 7-Benzyloxy-3,4,12,12a-tetrahydro-1H-1,4oxazino3,4-cpyrido2,1-f1,2,4triazine-6,8-dione | 1370250-39-7 |  |
Baloxavir Marboxil | Commercial |
| 20 | R-7-benzyloxy- 3,4,12,12a-tetrahydro- 1H-1,4oxazino3,4- cpyrido2,1-f1,2,4- triazine-6,8-dione | 1985607-70-2 |  |
Baloxavir Marboxil | Commercial |
| 21 | 7,8-difluorodibenzob,ethiepin-116H-one | 2136287-66-4 |  |
Baloxavir Marboxil | Commercial |
| 22 | 7,8-difluoro-6,11-dihydro-Dibenzob,ethiepin-11-ol | 1985607-83-7 |  |
Baloxavir Marboxil | Commercial |
| 23 | 4-Chlorobutanal dimethyl acetal | 29882-07-3 |  |
Sumatriptan | Commercial |
| 24 | 4-N,N-Dimethylaminobutanal Dimethyl Acetal | 19718-92-4 |  |
Rizatriptan | Commercial |
| 25 | 4-Chlorobutanal diethyl acetal | 6139-83-9 |  |
Almotriptan | Commercial |
| 26 | 4,4-Diethoxy-N,N-dimethyl-1-butanamine | 1116-77-4 |  |
Zolmitriptan | Commercial |
| 27 | Carbamic acid, N-1S-1,2,3,4-tetrahydro-4-oxo-1-naphthalenyl-, 1,1-dimethylethyl ester | 2095345-15-4 |  |
Tegileridine Fumarate | Commercial |
| 28 | 2-9-pyridin-2-yl-6-oxaspiro4.5decan-9-ylacetonitrile | 1401031-37-5 |  |
Tegileridine Fumarate | Commercial |
| 29 | S-N1-2-aminoethyl-3-4-ethoxyphenylpropane-1,2-diamine.3HCl | 221640-06-8 |  |
Gadoxetate Disodium | Commercial |
| 30 | L-Tyrosine, N-1,1-dimethylethoxycarbonyl-O-ethyl-, methyl ester | 92507-32-9 |  |
Gadoxetate Disodium | Commercial |
| 31 | Boc-L-TyrEt-oL | 1252686-29-5 |  |
Gadoxetate Disodium | Commercial |
| 32 | 2-9-pyridin-2-yl-6-oxaspiro4.5decan-9-ylacetonitrile | 1401031-37-5 |  |
Oliceridine | Commercial |
| 33 | 4-Benzyloxyphenylhydrazine hydrochloride | 52068-30-1 |  |
Etrasimod | Commercial |
| 34 | 2-Pyridinol-1-oxide | 13161-30-3 |  |
Catalyst | Commercial |
| 35 | NNDIC | 693-13-0 |  |
Catalyst | Commercial |
| 36 | EDC.HCL | 25952-52-8 |  |
Catalyst | Commercial |
